At its June 27 meeting in London, the Accreditation Board of the European Quality Improvement System (EQUIS) rendered its decision to re-accredit the ƽÌØÎå²»ÖÐ Desautels Faculty of Management for a second five-year period – the maximum term granted by the European Foundation for Management Development (EFMD) through EQUIS.
At its June 27 meeting in London, the Accreditation Board of the European Quality Improvement System (EQUIS) rendered its decision to re-accredit the ƽÌØÎå²»ÖÐ Desautels Faculty of Management for a second five-year period – the maximum term granted by the European Foundation for Management Development (EFMD) through EQUIS.
At its June 12 meeting in London, the Accreditation Board of the European Quality Improvement System (EQUIS) rendered its decision to re-accredit the Desautels Faculty of Management for a five-year period – the maximum term granted by the European Foundation for Management Development (EFMD) through EQUIS.
Dear Clinical Pharmacology and Toxicology Program Committee Members and Faculty and Faculty Members of the Department of Psychiatry;
Ìý
Dear all,
It is my great pleasure to announce to you that our program has received full accreditation status from the Royal College of Physicians and Surgeons of Canada. The surveyors were impressed with the overall quality of the program, the dedicated faculty members, the high caliber of residents, and the positive atmosphere of collaboration and commitment to educational excellence. I would like to thank all of you for your help with the accreditation and your constant support and participation in the residency program.
Ìý
Sincerely,
Karl